Target intelligence / Profile preview

Novel transcript, overlapping C16orf73 (AL031722.1)

Target: AL031722.1
Molecular classification: Other (uncharacterized lncRNA)

Overview

This gene, identified as ENSG00000260541 and also known as AL031722.1, is annotated as a "novel transcript, overlapping C16orf73" in the human genome. It has been classified as a long non-coding RNA (lncRNA), overlapping the C16orf73 locus. There are no known protein products, defined molecular functions, or links to therapeutic targeting. There is no evidence from databases or the primary literature indicating any role in disease, druggability, or biomarker utility. Its annotation as a "novel transcript" often results from computational gene prediction and transcriptomics data without functional validation or biological characterization[1][3].

Other names: AL031722.1

Beyond the preview

Go deeper on Novel transcript, overlapping C16orf73 (AL031722.1).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Explore the programs pursuing this target and their development progress.

Drug candidates
Developers
Development stage

Clinical trials

Follow the clinical studies evaluating therapies directed at this target.

Trial design
Status
Readouts

Competitive landscape

Compare approaches across drug candidates, modalities, and indications.

Programs
Modalities
Indications

Literature & evidence

Investigate the research and source evidence behind target biology and development.

Publications
Sources
Analysis

Patents

Explore patent activity around therapies and technologies addressing this target.

Patents
Assignees
Technologies

Research & analysis

Connect target biology, drug development, and emerging evidence in your research.

Biology
Development news
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Novel transcript, overlapping C16orf73 (AL031722.1).

Explore the full profile